Literature DB >> 28836225

PET should not replace routine SPECT MPS for the assessment of patients with known or suspected CAD.

James E Stirrup1, S Richard Underwood2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28836225     DOI： 10.1007/s12350-017-1023-8

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  21 in total

1.  Impact of myocardial perfusion imaging with PET and (82)Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management.

Authors:  Michael E Merhige; William J Breen; Victoria Shelton; Teresa Houston; Brian J D'Arcy; Anthony F Perna
Journal:  J Nucl Med       Date:  2007-07       Impact factor: 10.057

2.  Economic outcomes in the Study of Myocardial Perfusion and Coronary Anatomy Imaging Roles in Coronary Artery Disease registry: the SPARC Study.

Authors:  Mark A Hlatky; David Shilane; Rory Hachamovitch; Marcelo F Dicarli
Journal:  J Am Coll Cardiol       Date:  2014-03-18       Impact factor: 24.094

Review 3.  Cardiac PET perfusion tracers: current status and future directions.

Authors:  Jamshid Maddahi; René R S Packard
Journal:  Semin Nucl Med       Date:  2014-09       Impact factor: 4.446

4.  Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction.

Authors:  R Hachamovitch; D S Berman; L J Shaw; H Kiat; I Cohen; J A Cabico; J Friedman; G A Diamond
Journal:  Circulation       Date:  1998-02-17       Impact factor: 29.690

5.  Comparison of the diagnostic accuracies of very low stress-dose with standard-dose myocardial perfusion imaging: Automated quantification of one-day, stress-first SPECT using a CZT camera.

Authors:  Tali Sharir; Marina Pinskiy; Abraham Pardes; Arik Rochman; Vitali Prokhorov; Gil Kovalski; Konstantine Merzon; Andrzej Bojko; Boris Brodkin
Journal:  J Nucl Cardiol       Date:  2015-05-27       Impact factor: 5.952

6.  Cost-effectiveness of functional cardiac testing in the diagnosis and management of coronary artery disease: a randomised controlled trial. The CECaT trial.

Authors:  L Sharples; V Hughes; A Crean; M Dyer; M Buxton; K Goldsmith; D Stone
Journal:  Health Technol Assess       Date:  2007-12       Impact factor: 4.014

7.  Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography.

Authors:  Daniel S Berman; Jamshid Maddahi; B K Tamarappoo; Johannes Czernin; Raymond Taillefer; James E Udelson; C Michael Gibson; Marybeth Devine; Joel Lazewatsky; Gajanan Bhat; Dana Washburn
Journal:  J Am Coll Cardiol       Date:  2012-12-19       Impact factor: 24.094

8.  Quantification of Myocardial Perfusion Reserve Using Dynamic SPECT Imaging in Humans: A Feasibility Study.

Authors:  Simona Ben-Haim; Venkatesh L Murthy; Christopher Breault; Rayjanah Allie; Arkadiusz Sitek; Nathaniel Roth; Jolene Fantony; Stephen C Moore; Mi-Ae Park; Marie Kijewski; Athar Haroon; Piotr Slomka; Kjell Erlandsson; Rafael Baavour; Yoel Zilberstien; Jamshed Bomanji; Marcelo F Di Carli
Journal:  J Nucl Med       Date:  2013-04-11       Impact factor: 10.057

9.  Comparison of cardiovascular magnetic resonance and single-photon emission computed tomography in women with suspected coronary artery disease from the Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease (CE-MARC) Trial.

Authors:  John P Greenwood; Manish Motwani; Neil Maredia; Julia M Brown; Colin C Everett; Jane Nixon; Petra Bijsterveld; Catherine J Dickinson; Stephen G Ball; Sven Plein
Journal:  Circulation       Date:  2013-12-19       Impact factor: 29.690

Review 10.  Myocardial perfusion scintigraphy: the evidence.

Authors:  S R Underwood; C Anagnostopoulos; M Cerqueira; P J Ell; E J Flint; M Harbinson; A D Kelion; A Al-Mohammad; E M Prvulovich; L J Shaw; A C Tweddel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.